Deferred Tax Assets, Valuation Allowance of ETHEMA HEALTH Corp from 30 Jun 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ETHEMA HEALTH Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2012 to 31 Dec 2024.
  • ETHEMA HEALTH Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $6,803,530, a 8.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ETHEMA HEALTH Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $6,803,530 +$534,124 +8.5% 31 Dec 2024 10-K 23 May 2025 2024 FY
Q4 2023 $6,269,406 +$2,401,894 +62% 31 Dec 2023 10-K 23 May 2025 2024 FY
Q4 2022 $3,867,512 31 Dec 2022 10-K 31 Mar 2023 2022 FY
Q4 2016 $104,169 -$20,303,013 -101% 31 Dec 2016 10-K 17 Apr 2017 2016 FY
Q4 2015 $20,198,844 +$632,815 +3.2% 31 Dec 2015 10-K/A 18 Apr 2016 2015 FY
Q3 2015 $19,868,367 +$7,609,218 +62% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 $19,914,883 +$7,547,821 +61% 30 Jun 2015 10-Q 19 Aug 2015 2015 Q2
Q1 2015 $12,259,149 -$298,873 -2.4% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 $19,566,029 +$1,900,273 +11% 31 Dec 2014 10-K/A 18 Apr 2016 2015 FY
Q3 2014 $12,259,149 +$1,220,933 +11% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 $12,367,062 +$1,360,475 +12% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $12,558,022 +$1,877,988 +18% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 $17,665,756 +$7,361,854 +71% 31 Dec 2013 10-K 16 Apr 2015 2014 FY
Q3 2013 $11,038,216 +$1,167,131 +12% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 $11,006,587 +$1,552,860 +16% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 $10,680,034 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q4 2012 $10,303,902 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q3 2012 $9,871,085 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $9,453,727 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.